week 11 Flashcards
what is asthma
chronic inflammatory disease of the airways =
activation of mast cells, infiltration of
eosinophils, and T helper 2 (TH2)
lymphocytes.
what makes asthma people different to average person
they have hyperresponsivness airways/over react
hyperplasia
= an increase in cell proliferation in a normal tissue or organ causing enlargement of a tissue or organ. (increase in number)
hypertrophy
= an increase and growth of muscle cells. (increase in size)
fibrosis
= thickening or scarring of the tissue. Fibrous connective tissue replaces normal tissue as a response to injury or damage (scarring).
oedema
= fluid retention
is asthma reversible
no
is COPD reversible
no
proteases
enzymes that catalyse the breakdown of proteins
are corticosteriods good for asthma & COPD
asthma yes
not for COPD
define COPD
pathological changes results on airway closure on expiration, leading to air trapping & hyperinflation
mainstream treatment of COPD
= bronchodilators
- reduce air trapping by dilating peripheral airways
- treatment aims to relief symptoms & reduce exacerbations
what can asthma be treated with
- corticosteroids
- not NSAIDs
- antagonists of muscarinic receptors
- agonists of adrenergic receptors
why are beta 2 used
u want the respiratory muscles to relax
what is the mechanism of beta 2 agonists as an effective bronchodilator
- stimulates beta2 adrenoceptors, causing the transducer (Gs) to break off and bind to aldynal cyclase, this in turn cycles ATP to cAMP which causes muscle relaxation of bronchial smooth muscle
what are the two classifications of B2 agonists
- SABA - salbutamol & terbutaline = short acting
2. LABA - e.b., formoterol*, indacaterol, salmeterol = long acting
SABA - salbutamol & terbutaline
= symptoms relief of asthma & COPD
= prevention of exercise induced bronchoconstriction, if taking before exercise it helps with breathless after exercise, short acting (30mins) but works straight away
LABA - e.b., formoterol*, indacaterol, salmeterol = long acting
= maintenance treatment of asthma in patients receiving inhaled corticosteroid (ICS)
= COPD
duration of action over 12 hours
how to minimise adverse effects of drugs used to treat asthma & COPD
use inhalers so it affects mainly the lungs = decreasing systemic adverse affect
common adverse effects of B2 agonists
inhalation = not problem
most common elderly = tremor, headache & palpitations = overtaken
what causes these adverse B2 agonist effects
more drugs reach the systemic circulation at higher doses leading on-target & off target effects elsewhere in the body rather then the lungs
B2 agonist cause tolerance & what is its effect
if take more then recommended = less receptors seen in the surface = down-regulation B2 receptors
does not reduce the bronchodilator response due to a large receptor reserve in airways smooth muscles
mechanism of action of anticholinergics
block muscarinic actions of acetylcholine preventing it to bind to receptor causing nerve induced bronchoconstriction & mucus secretion
= less effective then B2 agonists in asthma
what are the two classifications of anticholinergics
- SAMA - ioratropium (short acting)
2. LAMA - E.g., tiotropium, aclidinum, glycopyrronium
- SAMA - ioratropium (short acting)
symptoms relief of asthma & COPD
- LAMA - E.g., tiotropium, aclidinum, glycopyrronium
maintenance treatment of moderate to severe asthma as adjunct to standard treatment
- COPD
what does Gq do
Gq is a transducer that binds to the effector, phospholipase 3 make IP3 which will lead to calcium ssensitization = msucle contraction
define synergistic action
work together to get the same outcome e.g., B2 agonists and the anticholinergics M3 working together to cause muscle relaxation
what are common AD of anticholinergics
when inhaled = little to now systemic absorption decrease chance of adverse effects
mo= dry mouth & throat irritation
define hyperinflation
increase air trapping
what is first line therapy for asthma
SABA because they are most effective
what are the most effective anti-inflammatory agents used in asthma
corticosteriods = delayed effect = will need to be taken continuously = preventers
corticosteriod mechanism of action x4
- decreases transcription of genes that encode pro-inflammatory proteins
- activates transcription of anti-inflammatory genes
- directly interact with pro-inflammatory transcription factors
- reduce inflammatory cell numbers & their activation in the airways
pharmacokinetics of corticosteriods
- a portion of inhaled dose reaches system circulation
- part of dose is deposited, swallowed & absorbed from gut
- beclometasone & circlesonide are prodrugs activated by lung esterases = only active in the lungs which is where they are needed
- budesonide & fluticasone have a greater first-pass metabolism = broken down before reaching systemic circulation
common AD of corticosteriods
- oral candidiasis = white tongue
- hoarseness (dysphonia)
- facial skin irritation after nebulisation
bioavailability
amount of drug reaching systemic circulation unaltered = no first-pass metabolism